Filtros de búsqueda

Lista de obras de

A phase II trial of lenalidomide, dexamethasone and cyclophosphamide for newly diagnosed patients with systemic immunoglobulin light chain amyloidosis.

artículo científico

Bone marrow plasma cell infiltration in light chain amyloidosis: impact on organ involvement and outcome.

artículo científico publicado en 2018

Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial.

artículo científico publicado en 2016

Impact of response to treatment in health-related quality of life patient-reported outcomes in elderly patients with relapsed multiple myeloma

scientific article published on 15 September 2020

Initial features and outcome of cutaneous and non-cutaneous primary extranodal follicular lymphoma.

artículo científico publicado en 2011

International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)

artículo científico publicado en 2020

Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality

artículo científico publicado en 2020

Nectin-2 expression on malignant plasma cells is associated with better response to TIGIT blockade in multiple myeloma

artículo científico publicado en 2020

Prognostic impact of immunoparesis at diagnosis and after treatment onset in patients with light-chain amyloidosis.

artículo científico publicado en 2017

Six-2 glomerular expression for the prediction of renal outcome in systemic amyloidosis

scientific article published on 01 January 2019

The Changing Landscape of Smoldering Multiple Myeloma: A European Perspective

artículo científico publicado en 2016

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda